Full text
PDFPage 677
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CHAPMAN L. F., RAMOS A. O., GOODELL H., SILVERMAN G., WOLFF H. G. Definition of a humoral agent implicated in the mechanism of vascular headache of the migraine type. Trans Am Neurol Assoc. 1960;85:200–202. [PubMed] [Google Scholar]
- FRIEDMAN A. P., ELKIND A. H. Appraisal of methysergide in treatment of vascular headaches of migraine type. JAMA. 1963 Apr 13;184:125–128. doi: 10.1001/jama.1963.03700150079013. [DOI] [PubMed] [Google Scholar]
- GRAHAM J. R. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache. N Engl J Med. 1960 Dec 22;263:1273–1277. doi: 10.1056/NEJM196012222632502. [DOI] [PubMed] [Google Scholar]
- HALE A. R., REED A. F. Prophylaxis of frequent vascular headache with methysergide. Am J Med Sci. 1962 Jan;243:92–98. doi: 10.1097/00000441-196201000-00014. [DOI] [PubMed] [Google Scholar]
- ROOKE E. D., RUSHTON J. G., PETERS G. A. Vasodilating headache: a suggested classification and results of prophylactic treatment with UML 491 (methysergide). Proc Staff Meet Mayo Clin. 1962 Aug 15;37:433–443. [PubMed] [Google Scholar]
- SICUTERI F. Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine. Int Arch Allergy Appl Immunol. 1959;15:300–307. doi: 10.1159/000229055. [DOI] [PubMed] [Google Scholar]
- SOUTHWELL N., WILLIAMS J. D., MACKENZIE I. METHYSERGIDE IN THE PROPHYLAXIS OF MIGRAINE. Lancet. 1964 Mar 7;1(7332):523–524. doi: 10.1016/s0140-6736(64)92910-1. [DOI] [PubMed] [Google Scholar]